Stay updated with breaking news from Pharma Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Strides Pharma rises after USFDA nod for Prednisone tablets on Business Standard. Strides Pharma rose 2.96% to Rs 891.4 after the drug company announced that its step-down wholly owned subsidiary has received US drug regulator's approval for Prednisone tablets.
Strides Pharma Science - Steady quarter; Stelis to demerge - ICICI Securities
In order to continue its focus on core pharma business, Strides Pharma Science will be demerging its biotech business under Stelis Biopharma, said a top company official. The Board will form a Committee of Directors to explore various options of value discovery including listing of the business. “The biopharma business needs a lot of capital. At Strides, if we continue to put that capital in Stelis, it would be a challenge on our balance sheet. Our core business is growing extremely well particularly in regulated markets such as the US so we would want to continue to focus on where the gr...
Share this article Share this article ResearchAndMarkets.com's offering. The global ibuprofen market is projected to reach US$7.54 billion in 2024, progressing at a CAGR of 2.47%, over the period 2020-2024. The factors such as upsurge in healthcare expenditure, rising prevalence of arthritis, surging incidence of cancer cases, expanding urbanization and escalating sales of analgesic drugs would drive the growth of the market. However, the market growth would be challenged by adverse side effects and increase in the price of raw materials. A few notable trends include mounting e-commerce pene...
Read more about Indices open on firm note; breadth strong on Business Standard. Local stocks are trading firm in early trade on buying demand in index pivotals. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 357.81 points or 0.74% at 48,451.13. The Nifty 50 index was up 112.35 points or 0.79% at 14,249.70.